Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P01275 (
glucagon
)
26,492
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A technique has been devised to attach adult rat hepatocytes to collagen-coated dextran microcarriers. Cells were cultured serum-free for 2 d and their viability, enzyme activities, glucose metabolism, and hormone responsiveness were compared to data obtained from conventional dish cell culture. The two different culture methods showed no difference in cell viability and morphology. Microcarrier-cultured cells exhibited hormone responsiveness comparable to dish cultures; glycolysis could be activated three-fold by the sole addition of insulin, and gluconeogenesis was increased by 40 to 50% by
glucagon
. During the 48-h culture glucokinase and
phosphoenolpyruvate carboxykinase
activities declined at a similar rate in both culture systems. Long-term culture with 0.1 microM insulin prevented the decrease of glucokinase activity. Insulin responsiveness (activation of glycolysis) was still pronounced after 48 h in culture. The microcarrier technique establishes a new in vitro liver system in which acute and long-term hormonal actions can be investigated using the technical advantages of a suspension culture.
...
PMID:Adult rat hepatocyte microcarrier culture. Comparison to the conventional dish culture system. 305 97
Birth in most mammalian species represents an abrupt change from a high-carbohydrate and low-fat diet to a high-fat and low-carbohydrate diet. Gluconeogenesis is absent from the liver of the fetus of well-fed mothers, but can be induced prematurely by prolonged fasting of the mother. Gluconeogenesis increases rapidly in the liver of newborn mammals in parallel with the appearance of
phosphoenolpyruvate carboxykinase
(
PEPCK
), the rate-limiting enzyme of this pathway. The rise in plasma
glucagon
and the fall in plasma insulin which occur immediately after birth are the main determinants of liver
PEPCK
induction. When liver
PEPCK
has reached its adult value, i.e. 24 h after birth, other factors are involved in the regulation of hepatic gluconeogenesis. In order to maintain a high gluconeogenic rate, the newborn liver must be supplied with sufficient amount of gluconeogenic substrates and free fatty acids. An active hepatic fatty acid oxidation is necessary to support hepatic gluconeogenesis by providing essential cofactors such as acetyl CoA and NADH. The relevance of animal studies for the understanding of neonatal glucose homeostasis in man is discussed.
...
PMID:[Hormonal control of the development of hepatic gluconeogenesis in the neonate]. 305 68
The induction of
phosphoenolpyruvate carboxykinase
(
PEPCK
) by
glucagon
was studied in primary rat hepatocyte cultures by determining the time course of the sequential events, increases in the enzyme's mRNA abundance, synthesis rate, amount and activity, and by investigating the antagonistic action of insulin on the induction by
glucagon
. 1. The mRNA of
PEPCK
was induced maximally 2-3 h after addition of 10 nM
glucagon
, as detected by Northern-blot analysis after hybridization with a biotinylated antisense RNA of
PEPCK
. 2. The synthesis rate of
PEPCK
increased maximally 2-3 h after application of
glucagon
as revealed by pansorbin-linked immunoprecipitation of [35S]methionine-labelled
PEPCK
. 3. The enzyme amount and activity was maximally induced 4 h after
glucagon
application. 4. The mRNA of
PEPCK
was half-maximally induced by 0.1 nM and maximally by 1 nM and 10 nM
glucagon
. The half-maximal induction by 0.1 nM
glucagon
was antagonized almost totally, and the maximal induction by 1 nM
glucagon
partially, while the maximal induction by 10 nM
glucagon
remained unaffected by 10 nM insulin. The results show that in cultured rat hepatocytes physiological concentrations of
glucagon
stimulated the induction of
PEPCK
by an increase in mRNA, that the
glucagon
-dependent increase in mRNA and enzyme-synthesis rate occurred in parallel and preceded the increase of enzyme amount and activity by 1-1.5 h, and that physiological levels of insulin antagonized the induction by
glucagon
in the physiological concentration range, with
glucagon
being the dominant hormone.
...
PMID:Regulation of the expression of the phosphoenolpyruvate carboxykinase gene in cultured rat hepatocytes by glucagon and insulin. 306 15
The effects of
glucagon
and the alpha-adrenergic agonist, phenylephrine, on the rate of 14CO2 production and gluconeogenesis from [1-14C]lactate and [1-14C]pyruvate were investigated in isolated perfused livers of 24-h-fasted rats. Both
glucagon
and phenylephrine stimulated the rate of 14CO2 production from [1-14C]lactate but not from [1-14C]pyruvate. Neither
glucagon
nor phenylephrine affected the activation state of the pyruvate dehydrogenase complex in perfused livers derived from 24-h-fasted rats. 3-Mercaptopicolinate, an inhibitor of the
phosphoenolpyruvate carboxykinase
reaction, inhibited the rates of 14CO2 production and glucose production from [1-14C]lactate by 50% and 100%, respectively. Furthermore, 3-mercaptopicolinate blocked the
glucagon
- and phenylephrine-stimulated 14CO2 production from [1-14C]lactate. Additionally, measurements of the specific radioactivity of glucose synthesized from [1-14C]lactate, [1-14C]pyruvate and [2-14C]pyruvate indicated that the 14C-labeled carboxyl groups of oxaloacetate synthesized from 1-14C-labeled precursors were completely randomized and pyruvate----oxaloacetate----pyruvate substrate cycle activity was minimal. The present study also demonstrates that
glucagon
and phenylephrine stimulation of the rate of 14CO2 production from [1-14C]lactate is a result of increased metabolic flux through the
phosphoenolpyruvate carboxykinase
reaction, and phenylephrine-stimulated gluconeogenesis from pyruvate is regulated at step(s) between phosphoenolpyruvate and glucose.
...
PMID:Regulation of gluconeogenesis from pyruvate and lactate in the isolated perfused rat liver. 309 74
Induction of cytosolic aspartate aminotransferase (cAspAT) was observed in rat liver on administration of a high-protein diet, or
glucagon
and during fasting. The enzyme activity in the liver of rats given 80% protein diet or
glucagon
injection during starvation increased to 2- to 2.4-fold that in the liver of rats maintained on 20% protein diet, with about 2-fold increases in the levels of hybridizable cAspAT mRNA, measured by blot analysis using the cloned rat cAspAT cDNA as a probe. No increase in the enzyme was detected in kidney, heart, brain, or skeletal muscle. The activity of mitochondrial aspartate aminotransferase (mAspAT) did not increase. Induction of cAspAT was observed when glucose metabolism tended toward gluconeogenesis. The physiological function of the induction of cAspAT is considered to be to increase the supply of oxaloacetate as a substrate for cytosolic
phosphoenolpyruvate carboxykinase
(
PEPCK
) [EC 4.1.1.32] for gluconeogenesis.
...
PMID:Rat cytosolic aspartate aminotransferase: regulation of its mRNA and contribution to gluconeogenesis. 318 50
We have determined that one reason for diminished
PEPCK
activity during endotoxemia is the inhibition of glucocorticoid action in hepatic cells. Since glucocorticoid and
glucagon
hormones act cooperatively to regulate the expression of
PEPCK
mRNA, we examined whether endotoxin also inhibits the action of
glucagon
to induce this enzyme. Treated mice were injected intraperitoneally with endotoxin and glucose after a 24 hr fast and given ad libitum access to food and water. Control mice received the same amount of glucose and access to food and water. All mice were given intravenous injections of
glucagon
for 3 consecutive hours before euthanasia. Blood was analyzed for glucose concentrations, and the liver was assayed for
PEPCK
activity. Refeeding control mice after a 24 hr fast increased plasma glucose levels to 173 +/- 14 mg/dL and decreased
PEPCK
activity to 20.6 +/- 2.0 units/mg liver. Subsequent administration of exogenous
glucagon
further increased plasma glucose to 224 +/- 17 mg/dL and hepatic
PEPCK
to 31.4 +/- 1.4 units/mg liver. Refeeding endotoxin-treated mice after a 24 hr fast slightly increased plasma glucose levels to 75 +/- 4 mg/dL but had no effect on
PEPCK
activity. Subsequent
glucagon
administration had no effect on plasma glucose levels (75 +/- 1.0 mg/dL) or hepatic
PEPCK
activities (18.8 +/- 5.0 units/mg liver). Therefore,
glucagon
action to increase liver
PEPCK
activity and plasma glucose levels was inhibited in endotoxin-treated mice.
...
PMID:Failure of glucagon to induce hepatic phosphoenolpyruvate carboxykinase in endotoxic shock. 320 22
Energy intake, weight gain, carcass composition, plasma hormones and fuels, hepatic metabolites and the activities of
phosphoenolpyruvate carboxykinase
(
PEPCK
), malic enzyme, and glucose 6-phosphate dehydrogenase (G6P-DH) were examined in adult rats during a 44-day period of low fat, high carbohydrate (LF) feeding or of consumption of one or two high (70% metabolizable energy) fat diets composed of 63% (metabolizable energy) long-chain (LCT) or medium-chain (MCT) triglycerides. Energy intake was similar in the LCT and MCT groups but was less than that of LF group. The weight gain of rats fed MCT diet was 30% less than that of rats fed LF or LCT diets. Energy retention was less when the diet provided MCT than LCT or LF, and that resulted in a 60% decrease in the daily lipids deposition. Plasma glucose, free fatty acids, glycerol, and insulin/
glucagon
ratio were similar in the three groups. Blood ketone body (KB) concentrations in rats fed the high fat diets were extremely elevated, particularly in the MCT group, but declined throughout the experiment and by the 44th day hyperketonemia decreased by 50% but remained higher than in the LF diet. The blood beta-hydroxybutyrate/acetoacetate (B/A) ratio remained slightly elevated in rats fed the high fat diets. Similar changes were observed in liver KB concentration and in the B/A ratio. Liver lactate/pyruvate ratio elevated in the LCT and MCT groups at the initiation of the diets decreased by 50% at the end of the experiment. The consumption of high fat diets led to a 1.5-fold increase in liver
PEPCK
activity.(ABSTRACT TRUNCATED AT 250 WORDS)
...
PMID:Metabolic effects induced by long-term feeding of medium-chain triglycerides in the rat. 329 41
The mechanisms of the responses of an enzyme to different hormones and metabolites or several enzymes to a single hormone are surprisingly varied. There is neither an operon for lipogenic enzymes nor a common step at which hormones and metabolites coordinately regulate the expression of lipogenic genes. In bacteria, coordinated expression of several enzymes in a single metabolic pathway often is achieved by organizing the genes into operons. An operon is a group of genes linked together in a linear fashion and producing a polycistronic mRNA. Trans-acting factors regulate the transcription of these genes by interacting with promoter/regulatory sequences in the 5'-flanking region of the most 5'-ward of the genes. In vertebrate animals, however, coordinated control of gene transcription is not achieved by linking the individual genes, but by putting in the 5'-flanking regions of these genes a regulatory sequence that interacts with common trans-acting factors. Genes controlled by different hormones are expected to have regulatory elements for each hormone. The presence of glucocorticoid and cyclic AMP regulatory elements at the 5'-end of the
PEPCK
gene is consistent with this notion. Transcription is not the only step at which hormones and metabolites control the pathways for gene expression. The levels of the mRNAs for L-PK, ME, S11, and S14 are increased by T3 at post-transcriptional steps.
Glucagon
also regulates the accumulation of ME mRNA post-transcriptionally. Neither the mechanism nor the sequence organization of regulatory elements is known for post-transcriptional control of gene expression. In the case of
PEPCK
and HMG-CoA reductase, the next steps will be to determine more precisely the sequences in the 5'-region that mediate hormone sensitivity and feedback inhibition, respectively, and whether trans-acting factors are involved. For the other genes discussed, identification of the regulated step must precede identification of sequences that confer hormone or metabolite-sensitive regulation on a specific gene. In general, it is probable that the hybrid gene approach, so successful for
PEPCK
and HMG-CoA reductase, also will be effective in defining cis-acting hormone- or metabolite-regulatory elements in other genes. These techniques should be applicable to both transcriptional and post-transcriptional mechanisms. Our long-term objective is to understand the molecular basis of each event that intervenes between the binding of hormone or metabolite to its appropriate receptor and altered enzyme level.(ABSTRACT TRUNCATED AT 400 WORDS)
...
PMID:Dietary regulation of gene expression: enzymes involved in carbohydrate and lipid metabolism. 330 Jul 31
We rendered pregnant rats chronically hyperinsulinemic to determine the effect of reduced maternal metabolic fuel availability on fetal growth and development. We implanted osmotically driven insulin loaded minipumps on day 14 (term 21.5 days) in pregnant rats. This significantly increased maternal plasma concentrations of insulin and reduced glucose from day 15 until term. From day 17 until birth, fetal growth was significantly less for hyperinsulinemic mothers (term birth weight 4.53 +/- 0.07 versus 5.64 +/- 0.06 g, p less than 0.001). In fetuses of hyperinsulinemic mothers plasma glucose and insulin concentrations were significantly reduced while
glucagon
concentrations were increased. Total plasma amino acids were significantly reduced in maternal rats and their fetuses from days 17 to 19 while arteriovenous blood gas tensions and pH did not differ between fetuses of hyperinsulinemic and control mothers. Small for gestational age newborn pups of hyperinsulinemic mothers were hypoglycemic for the first 240 min of life as a result of limited hepatic glycogen stores and a delay in the normally expected induction of hepatic cytosolic
phosphoenolpyruvate carboxykinase
. This occurred despite significant increases in neonatal plasma
glucagon
concentrations. These data indicate that limitation of maternal glucose and amino acids with normal placental gaseous exchange retards fetal growth, limits hepatic glycogen deposition, and delays neonatal
phosphoenolpyruvate carboxykinase
induction. Limited fetal insulin secretion resulting from diminished maternal fuel availability may have also been a factor in retarding growth. The delay in
phosphoenolpyruvate carboxykinase
induction despite enhanced
glucagon
secretion during fetal and neonatal life suggests a specific "resistance" to this hormone in the rat growth retarded by limited metabolic fuel availability.
...
PMID:Limited maternal fuel availability due to hyperinsulinemia retards fetal growth and development in the rat. 331 55
In primary cultures of rat hepatocytes the
glucagon
-dependent induction of
phosphoenolpyruvate carboxykinase
was studied in the presence of putative local hormone and substrate modulators which form clear concentration gradients during liver passage such as adenosine, ketone bodies and ammonia. 1) Adenosine inhibited the induction of
phosphoenolpyruvate carboxykinase
in a concentration-dependent manner between 50 and 200 microM up to 4 h after
glucagon
application; AMP had similar, adenine, inosine and guanosine had no effect. Adenosine was almost totally metabolized by the liver cells during the first 4 h of the induction period. The inhibitory action of adenosine was also observed using dibutyryl-cAMP or 8-bromo-cAMP as inducer; it could not be prevented by the adenosine receptor antagonist caffeine nor could it be mimicked by the selective adenosine receptor agonist N6-(phenylisopropyl)adenosine. 2) Acetoacetate suppressed the induction of
phosphoenolpyruvate carboxykinase
in a concentration-dependent manner between 5 and 20mM during the first 4 h after
glucagon
addition. beta-Hydroxybutyrate showed no effect. Neither starting with acetoacetate nor with beta-hydroxybutyrate did the cell cultures establish the thermodynamic equilibrium between the two compounds. 3) Ammonia did not affect induction of
phosphoenolpyruvate carboxykinase
at concentrations up to 2mM. Ammonia was converted to urea within the first 4 h; yet it remained at clearly hyperphysiological concentrations in the medium during that period. It is concluded that the
glucagon
-dependent induction of
phosphoenolpyruvate carboxykinase
was modulated by the local hormone adenosine via a mechanism not involving adenylate cyclase and by acetoacetate via an unknown mechanism. The inhibitory action of adenosine may, that of acetoacetate can hardly be physiologically relevant.
...
PMID:Modulation of the glucagon-dependent induction of phosphoenolpyruvate carboxykinase by adenosine, but not ketone bodies or ammonia in rat hepatocyte cultures. Possible significance for the zonal heterogeneity of liver parenchyma. 344 1
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>